Enhanced lipoplex-mediated gene expression in mesenchymal stem cells using reiterated nuclear localization sequence peptides

被引:37
作者
Hoare, Melissa
Greiser, Udo
Schu, Sabine
Mashayekhi, Kaveh
Aydogan, Emrah
Murphy, Mary
Barry, Frank
Ritter, Thomas
O'Brien, Timothy [1 ]
机构
[1] Natl Univ Ireland, Regenerat Med Inst, Natl Ctr Biomed Engn Sci, Galway, Ireland
基金
爱尔兰科学基金会;
关键词
enhanced gene delivery; lipofection; stem cells; NONVIRAL VECTORS; DELIVERY; THERAPY; DNA;
D O I
10.1002/jgm.1426
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Background Mesenchymal stem cells (MSC) are widely regarded as a promising tool for cellular therapy applications, and genetic modification by safe, liposome-based vectors may enhance their therapeutic potential. Methods The present study describes the use of a cationic lipid vector (Lipofectamine 2000 (TM)) to deliver genes to MSC isolated from a number of species in vitro and determined the characteristics of this vector system in terms of dose, toxicity and the time course of expression. In addition, the optimal use of a nuclear localization sequence (NLS) to enhance gene expression was explored. Results Lipofection of human MSC did not adversely affect their ability to differentiate into osteogenic- and adipogenic lineages. Although human and rat MSC were found to take up lipoplexes with relative efficiency, lower levels of gene expression were detected in rabbit MSC, demonstrating a crucial effect of species. Peptides containing reiterated motifs of NLS were found to significantly improve on the level of transgene expression. Optimal gene delivery was observed when a three-fold reiterated NLS sequence was included in the liposome formulation. Conclusions Thus, nonviral gene delivery to MSC is feasible with efficiency being species dependent and can be enhanced by use of a three-fold reiterated NLS. Copyright (C) 2010 John Wiley & Sons, Ltd.
引用
收藏
页码:207 / 218
页数:12
相关论文
共 24 条
  • [1] Nucleofection is an efficient nonviral transfection technique for human bone marrow-derived mesenchymal stem cells
    Aluigi, Michela
    Fogli, Miriam
    Curti, Antonio
    Isidori, Alessandro
    Gruppioni, Elisa
    Chiodoni, Claudia
    Colombo, Mario P.
    Versura, Piera
    D'Errico-Grigioni, Antonia
    Ferri, Elisa
    Baccarani, Michele
    Lemoli, Roberto M.
    [J]. STEM CELLS, 2006, 24 (02) : 454 - 461
  • [2] Mesenchymal stem cells: clinical applications and biological characterization
    Barry, FP
    Murphy, JM
    [J]. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2004, 36 (04) : 568 - 584
  • [3] Factors influencing the ability of nuclear localization sequence peptides to enhance nonviral gene delivery
    Bremner, KH
    Seymour, LW
    Logan, A
    Read, ML
    [J]. BIOCONJUGATE CHEMISTRY, 2004, 15 (01) : 152 - 161
  • [4] Bremner KH, 2001, CURR OPIN MOL THER, V3, P170
  • [5] Towards safe, non-viral therapeutic gene expression in humans
    Glover, DJ
    Lipps, HJ
    Jans, DA
    [J]. NATURE REVIEWS GENETICS, 2005, 6 (04) : 299 - U29
  • [6] Human mesenchymal stem cells ectopically expressing full-length dystrophin can complement Duchenne muscular dystrophy myotubes by cell fusion
    Gonçalves, MAFV
    de Vries, AAF
    Holkers, M
    van de Watering, MJM
    van der Velde, I
    van Nierop, GP
    Valerio, D
    Knaän-Shanzer, S
    [J]. HUMAN MOLECULAR GENETICS, 2006, 15 (02) : 213 - 221
  • [7] LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1
    Hacein-Bey-Abina, S
    Von Kalle, C
    Schmidt, M
    McCcormack, MP
    Wulffraat, N
    Leboulch, P
    Lim, A
    Osborne, CS
    Pawliuk, R
    Morillon, E
    Sorensen, R
    Forster, A
    Fraser, P
    Cohen, JI
    de Saint Basile, G
    Alexander, I
    Wintergerst, U
    Frebourg, T
    Aurias, A
    Stoppa-Lyonnet, D
    Romana, S
    Radford-Weiss, I
    Gross, F
    Valensi, F
    Delabesse, E
    Macintyre, E
    Sigaux, F
    Soulier, J
    Leiva, LE
    Wissler, M
    Prinz, C
    Rabbitts, TH
    Le Deist, F
    Fischer, A
    Cavazzana-Calvo, M
    [J]. SCIENCE, 2003, 302 (5644) : 415 - 419
  • [8] A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency
    Hacein-Bey-Abina, S
    von Kalle, C
    Schmidt, M
    Le Deist, F
    Wulffraat, N
    McIntyre, E
    Radford, I
    Villeval, JL
    Fraser, CC
    Cavazzana-Calvo, M
    Fischer, A
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (03) : 255 - 256
  • [9] Researchers and regulators reflect on first gene therapy death
    Hollon, T
    [J]. NATURE MEDICINE, 2000, 6 (01) : 6 - 6
  • [10] Review: Gene- and stem cell-based therapeutics for bone regeneration and repair
    Kimelman, Nadav
    Pelled, Gadi
    Helm, Gregory A.
    Huard, J.
    Schwarz, Edward M.
    Gazit, Dan
    [J]. TISSUE ENGINEERING, 2007, 13 (06): : 1135 - 1150